CAPLIPOINT

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Caplin Point Laboratories Limited

Caplin Point Laboratories Limited, a Specialty & Generic Drug Manufacturer in the Healthcare sector, develops, produces, markets, and exports generic formulations and branded produ...

हिन्दी में

Caplin Point Laboratories Limited, स्वास्थ्य सेवा क्षेत्र में एक विशेष और जेनेरिक दवा निर्माता, जेनेरिक फॉर्मूलेशन और ब्रांडेड उत्पादों का विकास, उत्पादन, विपणन और निर्यात करती है।...

₹2,649.1-1.14%1D
Previous trading day close · Data updates after market close
1W: -2.5%
1M: -5.9%
6M: +59.6%
1Y: +28.7%
71/100
GoodResearch Score
Market Cap
₹19.0K Cr
Mid Cap
P/E Ratio
30.35
Fair
P/B Ratio
5.73
Premium
ROE
20.5%
Strong
ROCE
22.0%
Excellent
Debt / Equity
0.00
Low debt
Div. Yield
0.3%
EV/EBITDA
24.55
Fair
52W Low: ₹1,500.3Current: ₹2,649.152W High: ₹2,990
At 77% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
82/100
Growth
Revenue, EPS, profit growth
77/100
Valuation
PE, PB, EV/EBITDA vs sector
42/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
30.35(Fair)
Forward P/E
23.93(Premium)
P/B Ratio
5.73(Premium)
P/S Ratio
8.80(Expensive)
EV/EBITDA
24.55(Expensive)
Dividend Yield
0.3%
5Y CAGR
30.1%(High growth)
Revenue Growth
19.6%(Moderate)
Profitability
ROE
20.5%(Excellent)
ROCE
22.0%(Excellent)
ROA
18.2%(Efficient)
Net Margin
29.1%(High)
EBITDA Margin
40.4%
Financial Health
Debt to Equity
0.00(Low debt)
Current Ratio
6.97(Healthy)
Quick Ratio
5.88(Good)
Interest Coverage
923.75x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
55(Neutral)
RSI Exp (14)
35(Neutral)
MACD
8.779(Bullish)
MACD Signal
30.232
BB Position
30%(Middle)
BB Width
13.39%(Normal)
ADX (14)
17.5(Sideways)
Williams %R
-75.8(Neutral)
MFI (14)
69(Neutral)
CCI (20)
-65(Neutral)
Stoch %K
24(Neutral)
ATR (14)
113.21(Avg True Range)
OBV (M)
19.1(Positive)
1W OBV Chg
-2.3%(Decreasing)
Rel Volume
0.58x(Normal)
Volatility
39.4%(Moderate)
Max DD 1Y
-42.1%(High loss)
Alpha (CAPM)
13.53%(Outperforming Nifty)
Return vs Nifty
23.0%(Beating Nifty)
EMA 200
2294.3
EMA 50
2635.9
SMA 200
2127.2
vs SMA 50
0.4%(Above SMA50)
vs SMA 200
24.5%(Above SMA200)
Volume
1.04L
Avg Vol 3M
1.8L
Shareholding Pattern
Promoter
70.6%
High confidence
FII
6.1%
DII / MF
2.1%
Share CAPLIPOINT
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.
Caplin Point Laboratories Limited (CAPLIPOINT) Share Price ₹2649.10 Today | StockSage Pro